Myelination

Myelination is a biological process, not a single molecule or receptor. It refers to the formation and maintenance of the myelin sheath—a fatty, multilayered membrane that wraps around axons in both the central and peripheral nervous systems. In the CNS, oligodendrocytes are responsible for producing myelin; in the PNS, Schwann cells perform this role. The primary function of myelination is to increase the speed and efficiency of electrical impulse transmission along nerve fibers by enabling saltatory conduction between nodes of Ranvier. This process is essential for normal brain development, cognitive function, motor skills acquisition, and overall neural health. Disruption or loss of myelination leads to various neurological diseases such as multiple sclerosis and certain inherited metabolic disorders. Note on target status: "Myelination" itself is not a therapeutic target but rather a physiological process involving many molecular targets (such as oligodendrocyte lineage cells or specific proteins like MBP/PLP). Therefore, it should not be listed as a canonical drug target; instead, individual molecules involved in regulating or executing myelination may serve as therapeutic targets. Summary judgment on correctness: "Myelination" is incorrectly specified if intended as a druggable molecular target; it describes a complex biological event/process rather than an individual protein/receptor/enzyme suitable for direct pharmacological targeting.

Other names

MyelinogenesisMyelination processFormation of myelin sheath